{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Osteoarthritis%2C+Spine&page=12", "query": { "condition": "Osteoarthritis, Spine", "page": 12 }, "page_size": 10 }, "pagination": { "page": 12, "page_size": 10, "total_count": 299, "total_pages": 30, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Osteoarthritis%2C+Spine&page=13&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Osteoarthritis%2C+Spine&page=11&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-15T04:43:47.379Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02008916", "title": "16-week Efficacy and 3-year Safety, Tolerability and Efficacy of Secukinumab in Active Ankylosing Spondylitis Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Spondylitis, Ankylosing" ], "interventions": [ { "name": "Secukinumab", "type": "DRUG" }, { "name": "Placebo secukinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 226, "start_date": "2014-01-14", "completion_date": "2017-12-11", "has_results": true, "last_update_posted_date": "2019-01-08", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 14, "location_summary": "Mobile, Alabama • Mesa, Arizona • Peoria, Arizona + 11 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Mesa", "state": "Arizona" }, { "city": "Peoria", "state": "Arizona" }, { "city": "Upland", "state": "California" }, { "city": "Palm Harbor", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02008916" }, { "nct_id": "NCT04009499", "title": "A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriatic Arthritis" ], "interventions": [ { "name": "Bimekizumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "UCB Biopharma SRL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1131, "start_date": "2019-08-13", "completion_date": "2026-05-26", "has_results": false, "last_update_posted_date": "2026-09-04", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 31, "location_summary": "Phoenix, Arizona • San Diego, California • Palm Harbor, Florida + 28 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "San Diego", "state": "California" }, { "city": "Palm Harbor", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04009499" }, { "nct_id": "NCT04269993", "title": "Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Cannabis: placebo and medium THC/medium CBD", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brown University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 3, "start_date": "2022-05-18", "completion_date": "2023-07-31", "has_results": true, "last_update_posted_date": "2025-04-01", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 1, "location_summary": "Providence, Rhode Island", "locations": [ { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04269993" }, { "nct_id": "NCT01797224", "title": "OTIS Cimzia Pregnancy Registry", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Crohn's Disease", "Rheumatoid Arthritis", "Ankylosing Spondylitis", "Psoriatic Arthritis", "Psoriasis" ], "interventions": [], "intervention_types": [], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "FEMALE", "summary": "Female only" }, "enrollment_count": 925, "start_date": "2012-03", "completion_date": "2026-03", "has_results": false, "last_update_posted_date": "2025-01-28", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01797224" }, { "nct_id": "NCT04806620", "title": "Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Post-Acute COVID-19 Syndrome", "ME/CFS", "Rheumatic Arthritis", "Juvenile Rheumatoid Arthritis (JRA)", "Psoriatic Arthritis (PsA)", "Ankylosing Spondylitis (AS)", "Autoimmune Encephalitis", "Celiac Disease", "Celiac Disease in Children", "Chronic Lyme Disease", "Post-treatment Lyme Disease Syndrome", "Crohn's Disease", "Dysautonomia", "Anorexia Nervosa", "Bulimia Nervosa", "ARFID", "Avoidant / Restrictive Food Intake Disorder", "Ehlers Danlos Syndrome", "Endometriosis", "Fibromyalgia (FM)", "Long COVID", "Lupus", "Migraines", "Mast Cell Activation Syndrome", "Multiple Sclerosis", "Myalgic Encephalomyelitis (ME)", "Myasthenia Gravis, Generalized", "Myasthenia Gravis in Children", "Narcolepsy", "Obsessive Compulsive Disorder (OCD)", "PANDAS", "Pediatric Acute-onset Neuropsychiatric Syndrome (PANS)", "POTS - Postural Orthostatic Tachycardia Syndrome", "General Anxiety Disorder, Social Anxiety Disorder", "PTSD - Post Traumatic Stress Disorder", "Psoriasis", "Traumatic Brain Injury", "Tourette's Syndrome", "Inflammatory Bowel Disease (IBD)", "Autoimmune Diseases", "Neurological Diseases or Conditions", "Psychiatric Disorder", "Sjogren's Syndrome", "Ulcerative Colitis and Crohn's Disease" ], "interventions": [], "intervention_types": [], "sponsor": "Brain Inflammation Collaborative", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 10000, "start_date": "2023-07-05", "completion_date": "2030-12-31", "has_results": false, "last_update_posted_date": "2026-01-22", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 1, "location_summary": "Delafield, Wisconsin", "locations": [ { "city": "Delafield", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT04806620" }, { "nct_id": "NCT04156620", "title": "Study to Demonstrate the Efficacy, Safety and Tolerability of an Intravenous Regimen of Secukinumab Compared to Placebo in Subjects With Active axSpA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "Secukinumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 527, "start_date": "2019-12-11", "completion_date": "2022-12-20", "has_results": true, "last_update_posted_date": "2024-06-18", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 25, "location_summary": "Irvine, California • La Mesa, California • San Leandro, California + 22 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "San Leandro", "state": "California" }, { "city": "Upland", "state": "California" }, { "city": "Ocoee", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04156620" }, { "nct_id": "NCT03350815", "title": "Study Estimating the Clinical Difference Between 300 mg and 150 mg of Secukinumab Following Dose Escalation to 300 mg in Patients With Ankylosing Spondylitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Ankylosing Spondylitis" ], "interventions": [ { "name": "150 mg open-label secukinumab", "type": "DRUG" }, { "name": "150 mg double-blinded secukinumab", "type": "DRUG" }, { "name": "300 mg double-blinded secukinumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 322, "start_date": "2018-03-13", "completion_date": "2021-05-29", "has_results": true, "last_update_posted_date": "2022-04-29", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 65, "location_summary": "Jonesboro, Arkansas • Fullerton, California • Loma Linda, California + 60 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fullerton", "state": "California" }, { "city": "Loma Linda", "state": "California" }, { "city": "Palm Desert", "state": "California" }, { "city": "Tustin", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03350815" }, { "nct_id": "NCT03409211", "title": "Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "PEVCO", "type": "DIETARY_SUPPLEMENT" }, { "name": "Dietary Supplement Capsules without Coconut Oil", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "NYU Langone Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 22, "start_date": "2017-12-12", "completion_date": "2019-09-30", "has_results": false, "last_update_posted_date": "2020-12-02", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT03409211" }, { "nct_id": "NCT01690299", "title": "Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "Apremilast", "type": "DRUG" }, { "name": "Etanercept", "type": "DRUG" }, { "name": "Placebo tablet", "type": "DRUG" }, { "name": "Placebo injection", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Amgen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 250, "start_date": "2012-10-01", "completion_date": "2016-04-04", "has_results": true, "last_update_posted_date": "2022-03-15", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Bakersfield, California • Irvine, California + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01690299" }, { "nct_id": "NCT04846010", "title": "Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sequelae of; Infection", "Post Infection Glomerulonephritis", "Post-Infectious Peripheral Neuralgia", "Post-Infectious Disorder (Disorder)", "Post-Infectious Arthritis", "Post-Infectious Polyneuritis", "Post-Infectious Parkinsonism", "Post-Infectious Hypothyroidism", "Post Infectious Osteoarthritis", "Anxiety Disorders", "Depression", "Depression, Anxiety", "Depression, Bipolar", "Insomnia", "GERD", "Gastro Esophageal Reflux", "Hepatitis", "Glomerulonephritis" ], "interventions": [ { "name": "PurWet", "type": "COMBINATION_PRODUCT" }, { "name": "FurFat", "type": "COMBINATION_PRODUCT" }, { "name": "PurApo", "type": "COMBINATION_PRODUCT" }, { "name": "PurPhl", "type": "COMBINATION_PRODUCT" }, { "name": "PurClo", "type": "COMBINATION_PRODUCT" }, { "name": "PurInf", "type": "COMBINATION_PRODUCT" }, { "name": "Smoliv", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "All Natural Medicine Clinic, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2000, "start_date": "2021-03-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2021-05-26", "last_synced_at": "2026-10-15T04:43:47.379Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04846010" } ] }